title: Superparamagnetic particles as an oral contrast agent in abdominal magnetic resonance imaging.
authors.affiliation: Nycomed AS, Oslo, Norway.
authors.forename: A N
authors.initials: AN
authors.lastname: Oksendal
authors.forename: T F
authors.initials: TF
authors.lastname: Jacobsen
authors.forename: H G
authors.initials: HG
authors.lastname: Gundersen
authors.forename: P A
authors.initials: PA
authors.lastname: Rinck
authors.forename: E
authors.initials: E
authors.lastname: Rummeny
mesh_terms: D000005:Abdomen / Q000473:pathology*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D003911:Dextrans; D004341:Drug Evaluation; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects; D052203:Ferrosoferric Oxide; D006801:Humans; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D003287:Contrast Media; D003911:Dextrans; D005290:Ferric Compounds; D058185:Magnetite Nanoparticles; D010087:Oxides; C001215:ferrite; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide